Head-To-Head Contrast: KORU Medical Systems (NASDAQ:KRMD) & Autonomix Medical (NASDAQ:AMIX)

Autonomix Medical (NASDAQ:AMIX) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Valuation & Earnings

This table compares Autonomix Medical and KORU Medical Systems”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$15.43 million	($12.93)	-0.22
KORU Medical Systems	$28.52 million	6.43	-$13.74 million	($0.25)	-16.00

KORU Medical Systems has higher revenue and earnings than Autonomix Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by insiders. Comparatively, 21.7% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Autonomix Medical and KORU Medical Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-212.48%	-161.13%
KORU Medical Systems	-37.42%	-24.60%	-16.87%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Autonomix Medical and KORU Medical Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
KORU Medical Systems	0	1	3	1	3.00

Autonomix Medical presently has a consensus price target of $28.00, suggesting a potential upside of 875.61%. KORU Medical Systems has a consensus price target of $4.70, suggesting a potential upside of 17.50%. Given Autonomix Medical’s higher probable upside, analysts clearly believe Autonomix Medical is more favorable than KORU Medical Systems.

Summary

KORU Medical Systems beats Autonomix Medical on 8 of the 12 factors compared between the two stocks.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

About KORU Medical Systems

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.